Search

Daniel E. Kolker

Supervisory Patent Examiner (ID: 12246, Phone: (571)272-3181 , Office: P/1644 )

Most Active Art Unit
1649
Art Unit(s)
1645, 1649, 1644, 1646
Total Applications
545
Issued Applications
178
Pending Applications
76
Abandoned Applications
291

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7185011 [patent_doc_number] => 20050191711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto' [patent_app_type] => utility [patent_app_number] => 11/024223 [patent_app_country] => US [patent_app_date] => 2004-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7877 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191711.pdf [firstpage_image] =>[orig_patent_app_number] => 11024223 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/024223
Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto Dec 28, 2004 Abandoned
Array ( [id] => 7136744 [patent_doc_number] => 20050181478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/025607 [patent_app_country] => US [patent_app_date] => 2004-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 251 [patent_figures_cnt] => 251 [patent_no_of_words] => 275330 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181478.pdf [firstpage_image] =>[orig_patent_app_number] => 11025607 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/025607
Secreted and transmembrane polypeptides and nucleic acids encoding the same Dec 27, 2004 Abandoned
Array ( [id] => 5107003 [patent_doc_number] => 20070065881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Isolated cytotoxic factor associated with multiple sclerosis and method of detecting said cytotoxic factor' [patent_app_type] => utility [patent_app_number] => 10/582674 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13543 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065881.pdf [firstpage_image] =>[orig_patent_app_number] => 10582674 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/582674
Method of isolating cytotoxic heterocomplex associated with multiple sclerosis Dec 21, 2004 Issued
Array ( [id] => 7004589 [patent_doc_number] => 20050169902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers' [patent_app_type] => utility [patent_app_number] => 11/012849 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16223 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169902.pdf [firstpage_image] =>[orig_patent_app_number] => 11012849 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/012849
Methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers Dec 14, 2004 Issued
Array ( [id] => 5842245 [patent_doc_number] => 20060121039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration' [patent_app_type] => utility [patent_app_number] => 11/006161 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4688 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121039.pdf [firstpage_image] =>[orig_patent_app_number] => 11006161 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/006161
Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration Dec 6, 2004 Abandoned
Array ( [id] => 5715136 [patent_doc_number] => 20060078499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Use of hedgehog agonist to treat depression' [patent_app_type] => utility [patent_app_number] => 11/002769 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16319 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078499.pdf [firstpage_image] =>[orig_patent_app_number] => 11002769 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/002769
Use of hedgehog agonist to treat depression Nov 30, 2004 Abandoned
Array ( [id] => 5225015 [patent_doc_number] => 20070254281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Specific Marker Lmx1a on Dopaminergic Neurons' [patent_app_type] => utility [patent_app_number] => 10/580989 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19333 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254281.pdf [firstpage_image] =>[orig_patent_app_number] => 10580989 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/580989
Specific marker Lmx1a on dopaminergic neurons Nov 25, 2004 Issued
Array ( [id] => 7098437 [patent_doc_number] => 20050130896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Methods and compostions for inhibiting intracellular aggregate formation' [patent_app_type] => utility [patent_app_number] => 10/991197 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 22841 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130896.pdf [firstpage_image] =>[orig_patent_app_number] => 10991197 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/991197
Methods for identifying modulators of intracellular aggregate formation Nov 16, 2004 Issued
Array ( [id] => 8164458 [patent_doc_number] => 08173591 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Variants of pigment epithelium derived factor and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/718873 [patent_app_country] => US [patent_app_date] => 2004-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 14352 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173591.pdf [firstpage_image] =>[orig_patent_app_number] => 11718873 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/718873
Variants of pigment epithelium derived factor and uses thereof Nov 15, 2004 Issued
Array ( [id] => 7163971 [patent_doc_number] => 20050085629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Utilization of FPRL1 as a functional receptor by serum amyloid A (SAA)' [patent_app_type] => utility [patent_app_number] => 10/987664 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21234 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085629.pdf [firstpage_image] =>[orig_patent_app_number] => 10987664 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/987664
Utilization of FPRL1 as a functional receptor by serum amyloid A (SAA) Nov 11, 2004 Abandoned
Array ( [id] => 159040 [patent_doc_number] => 07674599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Methods of using antibodies to detect alpha-synuclein in fluid samples' [patent_app_type] => utility [patent_app_number] => 10/984192 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 12383 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674599.pdf [firstpage_image] =>[orig_patent_app_number] => 10984192 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/984192
Methods of using antibodies to detect alpha-synuclein in fluid samples Nov 7, 2004 Issued
Array ( [id] => 7136722 [patent_doc_number] => 20050181466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Immunosorbent blood tests for assessing paroxysmal cerebral discharges' [patent_app_type] => utility [patent_app_number] => 10/983845 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10949 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181466.pdf [firstpage_image] =>[orig_patent_app_number] => 10983845 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/983845
Immunosorbent blood tests for assessing paroxysmal cerebral discharges Nov 7, 2004 Issued
Array ( [id] => 7255869 [patent_doc_number] => 20050143287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/977113 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12174 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143287.pdf [firstpage_image] =>[orig_patent_app_number] => 10977113 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/977113
Primate prokineticin receptor polypeptides Oct 28, 2004 Issued
Array ( [id] => 5638034 [patent_doc_number] => 20060069008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Treatment of neurological deficits in the striatum or substanta nigra pars compacta' [patent_app_type] => utility [patent_app_number] => 10/952064 [patent_app_country] => US [patent_app_date] => 2004-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5972 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069008.pdf [firstpage_image] =>[orig_patent_app_number] => 10952064 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/952064
Treatment of neurological deficits in the striatum or substanta nigra pars compacta Sep 27, 2004 Abandoned
Array ( [id] => 5638035 [patent_doc_number] => 20060069009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Treatment of neurological deficits in the striatum or substanta nigra pars compacta' [patent_app_type] => utility [patent_app_number] => 10/952065 [patent_app_country] => US [patent_app_date] => 2004-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5054 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069009.pdf [firstpage_image] =>[orig_patent_app_number] => 10952065 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/952065
Treatment of neurological deficits in the striatum or substanta nigra pars compacta Sep 27, 2004 Abandoned
Array ( [id] => 4657127 [patent_doc_number] => 20080025988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Monoclonal Antibody And Use Thereof' [patent_app_type] => utility [patent_app_number] => 10/589969 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8013 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20080025988.pdf [firstpage_image] =>[orig_patent_app_number] => 10589969 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/589969
Monoclonal antibodies and use thereof Sep 15, 2004 Issued
Array ( [id] => 5204548 [patent_doc_number] => 20070026029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Apheresis device' [patent_app_type] => utility [patent_app_number] => 10/571469 [patent_app_country] => US [patent_app_date] => 2004-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7883 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026029.pdf [firstpage_image] =>[orig_patent_app_number] => 10571469 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/571469
Methods of treating Alzheimer's Disease with an apheresis device Sep 12, 2004 Issued
Array ( [id] => 7225539 [patent_doc_number] => 20050255122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Prevention and treatment of amyloidogenic disease' [patent_app_type] => utility [patent_app_number] => 10/934818 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26203 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255122.pdf [firstpage_image] =>[orig_patent_app_number] => 10934818 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/934818
Prevention and treatment of amyloidogenic disease Sep 1, 2004 Abandoned
Array ( [id] => 7082669 [patent_doc_number] => 20050048049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Prevention and treatment of amyloidogenic disease' [patent_app_type] => utility [patent_app_number] => 10/923474 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32271 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048049.pdf [firstpage_image] =>[orig_patent_app_number] => 10923474 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/923474
Prevention and treatment of amyloidogenic disease Aug 19, 2004 Abandoned
Array ( [id] => 7045132 [patent_doc_number] => 20050249727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Prevention and treatment of amyloidogenic disease' [patent_app_type] => utility [patent_app_number] => 10/923605 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32286 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249727.pdf [firstpage_image] =>[orig_patent_app_number] => 10923605 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/923605
Prevention and treatment of amyloidogenic disease Aug 19, 2004 Abandoned
Menu